Shuttle Pharmaceuticals Holdings, Inc. announced that it has entered into a securities purchase agreement with new investor, SRO, LLC to issue units for the gross proceeds of $2,250,000 on February 7, 2024. Each unit consists of one share of SHPH common stock and a warrant to purchase one share of SHPH common stock exercisable at a purchase price of $2.35 per share. The Units will be sold at a per Unit price equal to 90% of the VWAP of SHPH common stock for the five trading days immediately preceding closing.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4896 USD | -3.96% | -5.85% | +7.60% |
1st Jan change | Capi. | |
---|---|---|
+7.60% | 8.57M | |
+42.69% | 750B | |
+34.11% | 606B | |
-6.34% | 356B | |
+18.70% | 326B | |
+5.98% | 286B | |
+18.59% | 246B | |
-3.31% | 213B | |
+11.30% | 213B | |
+2.15% | 167B |
- Stock Market
- Equities
- SHPH Stock
- News Shuttle Pharmaceuticals Holdings, Inc.
- Shuttle Pharmaceuticals Holdings, Inc. announced that it expects to receive $2.25 million in funding